
ããªããæŠäºãçæŽ»è²»ãè¡æ¹äžæè ã«æ°ãåãããŠãããšãã«ãæ¿åºã¯ãã£ããCOVIDã¯ã¯ãã³æ¥çš®è ããšã€ãºãçºçããããšãçºè¡šããŸããã
å èšäºã¯ãã¡ããã/Click here to read the original article.
äœãã倧ããééã£ãŠãããããã¯ã³ãã19ã®æ³šå°ã®ããã ã
äžçäžã®æ¿åºãå ¬åŒããŒã¿ãçºè¡šããŠãããããããã¯ãã¹ãŠåãããšã瀺ããŠããããããããããã®æ¿åºã¯ãã®çç±ã説æããããšã¯ããªãã
ããã©ãããããŠã¯ã©ã€ãæŠäºã«æ°ãåãããçæŽ»è²»ãå¿é ããæ¿åºã®æ¿çã«ãã£ãŠåŒãèµ·ãããã屿©ããããŠè±åœã§ã¯90ç§ã«1人ãè¡æ¹äžæã«ãªã£ãŠããã®ã«ããã³ã©ã»ãã¬ã€ã®ãããªè¡æ¹äžæè ãããäžæ¹ã§ãããŒã¿ãæãæšãŠãããããšãæåŸ ããŠãéãã«ããŒã¿ãçºè¡šããŠããã®ã§ããã
ãããããã¡ã€ã¶ãŒç€Ÿã®æ©å¯ææžãå ¬éãããäžçäžã®æ¿åºãé ããå Žæã倱ãã€ã€ããããããããããå¿é ãªåŸåãç¶ãã°ãæ¿åºã¯ã³ããã19泚å°ãæäœäŸåæ§å¢åŒ·çããã£ãšæªããã®ãåŒãèµ·ãããŠãããšèªããããåŸãªããªãã§ãããã
åŸå€©æ§å ç«äžå šçå矀(ãšã€ãº)ã
ãŸãã«ã§ã¯ãããŸãããè¬ãå»è¬åãåŸå€©æ§å ç«äžå šçå矀ãåŒãèµ·ããããšã¯å®å šã«ããåŸãŸããã¹ã³ããã©ã³ãå ¬è¡è¡çå±ããã¥ãŒãžãŒã©ã³ãä¿å¥çãã«ããæ¿åºãè±åœå¥åº·å®å šå±ãåœå®¶çµ±èšå±ãç±³åœçŸç 察çã»ã³ã¿ãŒãçºè¡šããããŒã¿ã¯ãã³ããã19泚å°ããªã¹ãã«å ããããã¹ãããšã匷ã瀺åããŠããŸãã
äžçäžã®æ¿åºã¯ãå®å šãªã¯ã¯ãã³æ¥çš®è ãã¯ã¯ãã³éæ¥çš®è ãããã³ãã19ã«ææãã確çãé«ããã³ãã19ã§å ¥é¢ãã確çãé«ããã³ãã19ã§æ»äº¡ãã確çãé«ããšããäºå®ãä»ã«ã©ã説æã§ããã ãããïŒ
äžçäžã®æ¿åºã¯ãã¯ã¯ãã³æªæ¥çš®è ã«æ¯ã¹ãŠå®å šæ¥çš®è ã®å šæ»å æ»äº¡çãå€§å¹ ã«äžæããŠããããšããä»ã«ã©ã®ããã«èª¬æã§ããã ãããïŒ
2021幎ã«ç±³åœçŸç 察çã»ã³ã¿ãŒã®ã¯ã¯ãã³æå®³äºè±¡å ±åã·ã¹ãã ã«å ±åããããšã€ãºé¢é£çŸæ£ãçãææçã®1,145%ãã33,715%ã®å¢å ããäžçäžã®æ¿åºã¯ä»ã«ã©ã説æã§ããã§ããããïŒ
ã¹ã³ããã©ã³ã
ã¹ã³ããã©ã³ãå ¬è¡è¡çå±ã¯1æã«ã22幎2æ6æ¥ãããã¯ã¯ãã³æ¥çš®ç¶æ³å¥ã®Covid-19æ£è ãå ¥é¢ãæ»äº¡ã®å ±åãé±åäœã§è¡ããªãããšãçºè¡šããŸããã
ãã®çç±ã¯ä»¥äžã®éãã§ãã



äžã®ã°ã©ãã¯ãã¹ã³ããã©ã³ãå ¬è¡è¡çå±ã22幎2æ16æ¥ã«çºè¡šãããCOVID-19 & Winter Statistical Reportãã®æ°åãçšããŠäœæãããã®ã§ã10äžäººåœããã®ã³ããã19ææçãå ¥é¢çãæ»äº¡çããå®å šæ¥çš®è ã§ã¯åžžã«é«ããªã£ãŠããããšãããããŸãã
ããããCovid-19ã¯ã¯ãã³æ¥çš®ãã¹ã³ããã©ã³ãã®äººã ã«ããããããã®ã§ãã
ãã¥ãŒãžãŒã©ã³ã
以äžã®ã°ã©ãã¯ããã¥ãŒãžãŒã©ã³ãã«ããã1æ6æ¥ãã2æ11æ¥ãŸã§ãšã2æ12æ¥ãã2æ24æ¥ãŸã§ã®ã¯ã¯ãã³æ¥çš®ç¶æ³å¥ã®Covid-19ã®å®æ°å€ã瀺ããŠããŸãããã®ããŒã¿ã¯ã以äžã®ãã¥ãŒãžãŒã©ã³ãä¿å¥çã®å ¬åŒå ±åæžãCovid-19ãããæœåºãããã®ã§ããçäŸçµ±èšã¬ããŒã
'Covid-19: 2022幎2æ25æ¥çºè¡ã®ãCase Demographicsãã¬ããŒãã
Covid-19: Case Demographicsãã¬ããŒãïŒ2022幎2æ25æ¥çºè¡ïŒããCovid-19: 2022幎2æ12æ¥çºè¡ã®ãCovid-19: Case Demographicsãã¬ããŒãã§ãã
Covid-19: 2022幎1æ6æ¥çºè¡ã®ãCovid-19: Case Demographicsãã¬ããŒãã§ãã

ã©ã¡ãã®æéãå®å šãªã¯ã¯ãã³æ¥çš®ãåãã人ãCovid-19ã®çäŸã®å€§åãå ããŠããããšã¯ããããããã ãããšæããŸããã2æ12æ¥ãš2æ24æ¥ã®ã¯ã¯ãã³æ¥çš®ç¶æ³ã«ããçäŸæ°ã®å·®ã¯è¡æçãªãã®ã§ãã
次ã®å³ã¯ãäžèšã®çäŸãããšã«ã1æ6æ¥ãã2æ11æ¥ãŸã§ãšã2æ12æ¥ãã2æ24æ¥ãŸã§ã®ãã¥ãŒãžãŒã©ã³ãã«ãããã¯ã¯ãã³æ¥çš®ç¶æ³å¥ã®äººå£10äžäººåœããã®Covid-19æ£è çã瀺ãããã®ã§ããã

ãã®çäŸæ°ã¯ãã¹ã³ããã©ã³ãå ¬è¡è¡çå±ã®çäŸæ°ãšåæ§ããã¯ã¯ãã³æ¥çš®ã§ã³ããã19ã«ææãã確çãäžããããšèšã人ã®çãç«ã«ç¢ºå®ã«æ°Žã泚ãã§ããŸããïŒ
ã€ãŸããã³ããã-19ã®æ³šå°ã¯çŸå®çã«ã¯ãã€ãã¹å¹æã§ããããã¡ã€ã¶ãŒã®ã¯ã¯ãã³å¹æèšç®åŒã䜿ã£ãŠèšç®ããããšãã§ããã®ã§ãã
æªæ¥çš®äŸç-æ¥çš®äŸçïŒæªæ¥çš®äŸçïŒã¯ã¯ãã³æå¹æ§
以äžã®ã°ã©ãã¯ã1æ6æ¥ïœ2æ11æ¥ã2æ12æ¥ïœ22æ¥ïœã®2åæäžã®ã³ãã19ã®çŸå®ã®ã¯ã¯ãã³æå¹æ§ã瀺ããŠããŸãã

1æ6æ¥ãã2æ11æ¥ã®éã«ãçŸå®ã®ã³ãã19ã®ã¯ã¯ãã³å¹æã¯ãã€ãã¹94.4%ã§ããããšã蚌æããããã2æ24æ¥ã«ã¯çŸå®ã®ã¯ã¯ãã³å¹æã¯ãã€ãã¹281.35%ã«äœäžããŠãããããã¯ãå®å šæ¥çš®è ãæªæ¥çš®è ã»1åæ¥çš®è ã«æ¯ã¹ãŠ3.8åãCovid-19ã«ææãã確çãé«ãã£ãããšãæå³ããã
ããããäºéã¯ã¯ãã³æ¥çš®ããã¥ãŒãžãŒã©ã³ãã®äººã ã«ããããããã®ã§ããã
ã«ãã
æ¿åºã¯ãäœçŸäžäººãã®äººã ã«ã³ããã19ã®æ³šå°ã匷å¶ãããããªå³ããèŠå¶ã宿œããŠããããä»å¹Žã«å ¥ã£ãŠãããã«ããã§ã¯ã³ããã19ã®æ£è ãå ¥é¢ãæ»äº¡ããããŸã§ã§æå€§èŠæš¡ã§çºçããŠããã
ãªããïŒ
ã«ããæ¿åºã®å ¬åŒããŒã¿ã«ãããšã2022幎2æ21æ¥ãã4æ17æ¥ãŸã§ã«ãã¯ã¯ãã³æ¥çš®è å šäœãã³ããã19ã®çäŸãå ¥é¢ãæ»äº¡ã®5人ã«4人ãå ãããšããã
ãããã人å£10äžäººãããã®çäŸã»å ¥é¢ã»æ»äº¡çã¯ãåææã«3皮混åã¯ã¯ãã³æ¥çš®è ãæãé«ãããšã瀺ããŠããã
ãã®ããã3皮混åã¯ã¯ãã³ãæ¥çš®ãã人ã¯ãæªæ¥çš®ã®äººã«æ¯ã¹ãŠãå¹³åããŠã³ãã19ã«ææãã確çã4åãã³ãã19ã§å ¥é¢ãã確çã2åãã³ãã19ã§æ»äº¡ãã確çã3åé«ãããšãããŒã¿ã§ç€ºãããŠããŸãã
以äžã®ã°ã©ãã¯ã2022幎2æ21æ¥ãã4æ17æ¥ãŸã§ã®ã«ããå šåã«ãããã¯ã¯ãã³æ¥çš®ç¶æ³å¥ã®10äžäººåœããã®ã¯ã¯ãã³æ¥çš®è çã瀺ããŠããŸãã

以äžã®ã°ã©ãã¯ã2022幎2æ21æ¥ãã4æ17æ¥ãŸã§ã®ã«ããå šåã«ãããã¯ã¯ãã³æ¥çš®ç¶æ³å¥ã®10äžäººåœããã®å ¥é¢çã瀺ããŠããŸãã

以äžã®ã°ã©ãã¯ã2022幎2æ21æ¥ãã4æ17æ¥ãŸã§ã®ã«ããå šåã«ãããã¯ã¯ãã³æ¥çš®ç¶æ³å¥ã®10äžäººåœããã®æ»äº¡çã瀺ããŠããŸãã

ããããCovid-19ã®ã¯ã¯ãã³æ¥çš®ãã«ããã®äººã ã«ããããããã®ã§ãã
è±åœ
è±åœå¥åº·å®å šå±ãã¹ã³ããã©ã³ãå ¬è¡è¡çå±ãšåãããã«ã2022幎4æ1æ¥ä»¥éãã¯ã¯ãã³æ¥çš®ç¶æ³å¥ã®Covid-19æ£è ãå ¥é¢ãæ»äº¡ã®ããŒã¿ããã以äžå ¬è¡šããªãããšã«ããŠããã®ã§ãã
ãã®çç±ã¯ä»¥äžã®éãã§ãã



äžèšã®3ã€ã®ã°ã©ãã¯ãè±åœä¿å¥å®å šåºïŒUKHSAïŒã®ãã¯ã¯ãã³ãµãŒãã€ã©ã³ã¹ãå ±åæžã«å«ãŸããæ°å€ãå©çšããŠäœæããããã®ã§ããã
ãã®æ°åãèŠããšã2022幎ã®ç¬¬5é±ãã第13é±ãŸã§ã®æ£è çºççã¯ãã€ã³ã°ã©ã³ãã®ãã¹ãŠã®å¹Žéœ¢å±€ã§3皮混åã¯ã¯ãã³æ¥çš®è ãæãé«ãããšããããããããå ããªå·®ã§ã¯ãªããã¯ã¯ãã³æªæ¥çš®è ãš3皮混åã¯ã¯ãã³æ¥çš®è ã®å·®ã¯æããšã«æªåããŠããã
ãŸãã5é±ç®ãã9é±ç®ãŸã§ã®18-29æ³ãé€ããã¹ãŠã®å¹Žéœ¢å±€ã§ã10äžäººåœããã®Covid-19æ»äº¡çã2åæ¥çš®è ããé«ããªã£ãŠããã
ãããããã®å¹Žéœ¢å±€ã§ã¯ã¯ãã³æªæ¥çš®è ã®æ»äº¡çãé«ããªã£ãã®ã¯ç¬¬5é±ã®ã¿ã§ã第9é±ãšç¬¬13é±ã¯ã¯ã¯ãã³æªæ¥çš®è ãš2åæ¥çš®è ã®æ»äº¡çã¯åãã§ãã£ãã
å¯äžããã®åŸåãè±ããã®ã¯30-39æ³ã®å¹Žéœ¢å±€ã§ã13é±ç®ã«ã¯ã¯ã¯ãã³æªæ¥çš®è ã®æ»äº¡çããããã«é«ããªããªã©ãå転ããŠããããããããããé€ãã°ãä»ã®ãã¹ãŠã®å¹Žéœ¢å±€ã§ã¯ãä»å¹Žã®åãããäºéã¯ã¯ãã³æ¥çš®è ã®æ»äº¡çãé«ããªã£ãŠããã
ããã¯ãã¯ã¯ãã³ãæå¹ã§ããå Žåã«èŠãããã¹ãæ°åã§ã¯ãªããã¯ã¯ãã³ãæå¹ã§ãªãå Žåã«èŠãã¹ãæ°åã§ããªããç§ãã¡ãããã§èŠãŠããã®ã¯ãæå³ãã广ãšã¯æ£å察ã®å¹æãçºæ®ããŠããã¯ã¯ãã³ãªã®ã§ãã
次ã®2ã€ã®ã°ã©ãã¯ãäžèšã®æ»äº¡çã«åºã¥ããã€ã³ã°ã©ã³ãã®2åæ¥çš®è ã«ãããæ»äº¡ã«å¯ŸããçŸå®ã®Covid-19ã¯ã¯ãã³ã®å¹æã幎霢局å¥ã鱿°å¥ã«ç€ºãããã®ã§ããã
(ãã¡ã€ã¶ãŒã®ã¯ã¯ãã³èšç®åŒ
10äžäººåœããã®æªæ¥çš®ç-10äžäººåœããã®æ¥çš®ç÷10äžäººåœããã®æªæ¥çš®çÃ100ïŒã¯ã¯ãã³æå¹æ§ïŒ


æ»äº¡ã«å¯Ÿããã¯ã¯ãã³å¹æã¯ã2022幎9é±ç®ã«60ïœ69æ³ã§ãã€ãã¹111ïŒ ã70ïœ79æ³ã§ãã€ãã¹138ïŒ ã80æ³ä»¥äžã§ãã€ãã¹166ïŒ ãèšé²ããŠããŸãã
ãããã40ïœ49æ³ã®æ°åã ããèŠãŠãã ããã第5é±ã§ã¯æ»äº¡ã«å¯Ÿããã¯ã¯ãã³å¹æã¯ïŒ16ïŒ ãèšé²ãããããã9é±ç®ã«ã¯ãã€ãã¹32%ã«ãªã£ãããããã13é±ç®ã«ã¯ãã€ãã¹121ïŒ ãšããè¡æçãªæ°åã«ãªã£ãŠããã
ãããã®æ°åã¯ãã»ãšãã©ã®ããã«ã¯ã¯ãã³æ¥çš®è ããã¯ã¯ãã³æªæ¥çš®è ã«æ¯ã¹ãŠCovid-19ã§æ»äº¡ãã確çã2åã§ããããšã瀺ããŠããã
次ã®å³ã¯ãäžèšã®çäŸçã«åºã¥ãã2022幎1æ3æ¥ãã3æ27æ¥ãŸã§ã®ã€ã³ã°ã©ã³ãã«ããã幎霢局å¥ãé±å¥ã®3åæ¥çš®è ã«ãããå®éã®Covid-19ã¯ã¯ãã³å¹æã瀺ããŠããã

ããã§ã¯ããã¡ã€ã¶ãŒç€Ÿã䞻匵ããæå¹ç95ïŒ ã«ã¯å°åºåã°ãªãã®ã§ã¯ãªãã ãããïŒã¯ã¯ãã³å¹æã¯ã第5é±ã®ãã€ãã¹114.8%ããã第13é±ã«ã¯60-69æ³ã§ãã€ãã¹391.43%ãŸã§äœäžããŠããã
ããã§æãæ°ã«ãªãã®ã¯ã60-69æ³ãš70-79æ³ã®èœã¡èŸŒã¿ã§ã9é±ç®ãš13é±ç®ã®éã«åŽã£ã·ã¡ã«èœã¡ãŠããããã«èŠããããã ããããããããšã«ã18-29æ³ã¯ã第9é±ãã第13é±ã«ãããŠèœã¡èŸŒã¿ãéåããããã ãã第5é±ã®ãã€ãã¹29.8ïŒ ããããã€ãã¹231.22ïŒ ã«ãšã©ãŸã£ãŠããã
ãã®æ°åã¯ã60-69æ³ãã¯ã¯ãã³æªæ¥çš®ã®60-69æ³ãã5åè¿ãCovid-19ã«ææããããããšã瀺ããŠããã40-59æ³ãš70-79æ³ãã¯ã¯ãã³æªæ¥çš®ã®å幎代ãã4å以äžCovid-19ã«ææããå¯èœæ§ãããããšã瀺ããŠããŸãã
UKHSAã¯ãã¯ã¯ãã³ã®å¹æã¯æéã®çµéãšãšãã«å€§å¹ ã«è¡°ããã®ã§ãããŒã¹ã¿ãŒæäžãåããããšãéèŠã ãšäž»åŒµããŠããŸããããããããã¯åã§ãããã¯ã¯ãã³ã®å¹æã¯è¡°ããŸãããå ç«ç³»ã®æ§èœãäœäžããã®ã§ãã
ã¯ã¯ãã³ã®æå¹æ§ã¯ã¯ã¯ãã³ãè©äŸ¡ãããã®ã§ã¯ãªããã¯ã¯ãã³æ¥çš®ãåãã人ã®å ç«ã·ã¹ãã ã®ããã©ãŒãã³ã¹ããã¯ã¯ãã³æªæ¥çš®ã®äººã®å ç«ã·ã¹ãã ã®ããã©ãŒãã³ã¹ãšæ¯èŒããããšã§è©äŸ¡ãããã®ãªã®ã§ãã
ã¯ã¯ãã³å¹æã-50ïŒ ãšããããšã¯ãã¯ã¯ãã³æ¥çš®è ã®å ç«ç³»ãã¯ã¯ãã³æªæ¥çš®è ã®èªç¶å ç«ç³»ãããæªãããã©ãŒãã³ã¹ã瀺ãããã«ãªã£ããšããããšã§ããããã¯ãCovid-19ã¯ã¯ãã³ãå ç«ç³»ã«ãã¡ãŒãžãäžããããšãæå³ãããŸãã«ãã®æ°åã瀺ããŠããéããªã®ã§ãã
次ã®ã°ã©ãã¯ãäžèšã®çäŸæ°ã«åºã¥ããŠãã€ã³ã°ã©ã³ãã®3皮混åã¯ã¯ãã³æ¥çš®è ã®å ç«ç³»ã®ããã©ãŒãã³ã¹ã幎霢局å¥ã«1é±éãããã§ã¯ã¯ãã³æªæ¥çš®è ã®èªç¶å ç«ç³»ãšæ¯èŒãããã®ã§ãã
éœæ§å
ç«åïŒæªæ¥çš®äŸç-ã¯ã¯ãã³æ¥çš®äŸçïŒæªæ¥çš®äŸçÃ100
å
ç«ç³»é°æ§åçïŒæªæ¥çš®çäŸæ°-ã¯ã¯ãã³æ¥çš®çäŸæ°ïŒã¯ã¯ãã³æ¥çš®çäŸæ°Ã100

æãå ç«åãäœãã£ãã®ã¯60ïœ69æ³ã®ãã€ãã¹80ïŒ ã ãã30ïœ59æ³ã®ããªãã«ã¯ã¯ãã³æ¥çš®è å šå¡ããã€ãã¹75ïŒ ïœãã€ãã¹76ïŒ ãšã倧ããåŒãé¢ãããŠããªãã
18ïœ29æ³ã§ããã€ãã¹70ïŒ ã§ã51é±ç®ãš2é±ç®ã®éã«ïŒ11.35ïŒ ã ã£ãå ç«åãããã®é åã«å ¥ã£ãŠãããæãæ©ãå ç«åãäœäžããŠããããšã«ãªãã
60æ³ä»¥äžã§3åã®ãžã£ããåãã人ã¯ã2022幎ã«å ¥ã£ãŠããæ¥µããŠæ¥éã«å ç«ç³»ã®ããã©ãŒãã³ã¹ãäœäžããŠããããšãæããã«ãªã£ãã®ã§ãäžèšã®æ°åããéåžžã«å¿é ããå¿ èŠããããŸãã
ãããã60æ³æªæºã®äººã¯å¿é ããªããŠãããšããããã§ã¯ãªãããã§ã«å¹³åã§70ïœ76ïŒ äœäžããå ç«ã·ã¹ãã ã«æ©ãŸãããŠãã人ã°ãããªã®ã§ãã
ããããCovid-19ã¯ã¯ãã³æ¥çš®ãã€ã®ãªã¹äººãã¹ã³ããã©ã³ã人ããã¥ãŒãžãŒã©ã³ã人ãã«ãã人ããããŠããããäžçäžã®äººã ã«ããããããã®ãªã®ã§ãã
åé¡ã¯ããªããªã®ãïŒ
æäœäŸåæ§ãšã³ãã³ã¹ã¡ã³ãïŒ
é·å¹Žã«ãããå¥åº·å°éå®¶ã®éäžçãªç ç©¶ã«ããããæäœäŸåæ§å¢åŒ·ãïŒADEïŒã«ã€ããŠã®æžå¿µãé«ãŸã£ãŠããŸããããã¯ãã¯ã¯ãã³ãå ç«ç³»ãåºæ¿ããŠèŽåœçãªéå°åå¿ãåŒãèµ·ããããšã«ãããç æ°ãã¯ããã«æªåãããçŸè±¡ã§ãã
ADEã¯ããã€ãã®ç°ãªãæ¹æ³ã§çºçããŸãããæãããç¥ãããŠããã®ã¯ãããã€ã®æšéЬçµè·¯ããšåŒã°ãããã®ã§ããããã¯ãéå»ã®ææãã¯ã¯ãã³æ¥çš®ã«ãã£ãŠçæãããéäžåæäœããç åäœã«åã³ããããããšãã«ããã®ç åäœãã·ã£ããããŠã³ã§ããªãå Žåã«èµ·ãããã®ã§ããã
ããã€ã®æšéЬã¯ããŠã€ã«ã¹ãäŸµå ¥ããéåžžç«ã¡å ¥ãçŠæ¢ã®çްèïŒéåžžã¯ãã¯ããã¡ãŒãžãªã©ã®å ç«çްèïŒã§å¢æ®ããããšãå¯èœã«ããã²ãŒããŠã§ã€ãšããŠæ©èœããããã®çµæãç æ°ãèå»¶ããå ç«åå¿ãéå°ã«åå¿ããŠéçåããå¯èœæ§ãããã®ã§ãã
SARSãMERSã«å¯Ÿæããã¯ã¯ãã³åè£ã®éå»ã®èšåºè©Šéšã§ã¯ãç åæ§ãã©ã€ãã³ã°ããµã€ãã«ã€ã³ã¹ããŒã ãšããŠãç¥ãããADEã«ãããåç©æ®µéã§ãããã倱æããŠããŸãã
第3çžèšåºè©Šéšã¯ãã¯ã¯ãã³ã®äœ¿çšãæ¿èªãããåã«ãADEãå«ãé »åºŠã®é«ãå¯äœçšãé節ãªå¯äœçšãæããã«ããããã«è¡ãããŸãã
ããããããã§åé¡ãªã®ã¯ãCovid-19ã¯ã¯ãã³ã®ã©ããã第3çžèšåºè©Šéšãå®äºããŠããªãããšã§ããã
ãã¡ã€ã¶ãŒã®ç¬¬3çžèšåºè©Šéšã¯ã以åã¯2023幎4æã«å®äºãããšèŠç©ããããŠãããã2024幎2æ8æ¥ãŸã§å®äºããªãäºå®ã§ããã

ãããããã¡ã€ã¶ãŒããããŸã§è¡ã£ãŠããé²è¡äžã®ç ç©¶ã§ç §åããæ å ±ã®ãã¡ã2021幎2æã®æç¹ã§ãæäœäŸåæ§å¢åŒ·ãã³ãã19泚å°ã®çµæãšããŠèµ·ããããããšãååã«èªèããŠããããšã¯æããã§ããã2021幎4æã«ã¯ãã®çŸè±¡ãäººãæ®ºããŠããããšãç¥ã£ãŠãããšæãããŸãã

ã¯ã¯ãã³é¢é£åŒ·ååçŸæ£ïŒVAEDïŒã¯ãåãç åäœã«å¯Ÿããã¯ã¯ãã³æ¥çš®ãåããåŸã«éçåç åäœã«æŽé²ããã人ããããèšåºææçã®ä¿®æ£åçç¶ã§ãããVAEDã¯ãææãããŠã€ã«ã¹ãå¶åŸ¡ããããšãã詊ã¿ã倱æããå Žåã«åŒãèµ·ããããéåžžãææããç åäœã®æšçèåšã«é¢é£ããçç¶ãåããŸãã
ç§åŠè ã«ãããšãVAEDã¯ãæäœäŸåæ§å¢åŒ·ïŒADEïŒãšã¯ã¯ãã³é¢é£éæçïŒVAHïŒãšãã2ã€ã®ç°ãªãå ç«ç æ ãšããŠçºçãããšãããŠããŸãã
æäœäŸåæ§å¢åŒ·ã¯ãã¯ã¯ãã³æ¥çš®è ãã¯ã¯ãã³éæ¥çš®è ã«æ¯ã¹ãŠCovid-19ã§å ¥é¢ãããæ»äº¡ããããã確çã2åã«ãªãçç±ã確ãã«èª¬æããããã¯ã¯ãã³æ¥çš®è ãCovid-19ã«ææãã確çãæå€§ã§5åã«ãªãçç±ã説æã§ãããã©ããã¯åãããªãã
ææçãå ¥é¢ã»æ»äº¡çã®é«ãã説æã§ããããäžã€ã®æ¥µããŠæ·±å»ãªçŸæ£ã¯ãåŸå€©æ§å ç«äžå šçå矀ïŒAIDSïŒã§ããã
åŸå€©æ§å ç«äžå šçå矀ïŒ
åŸå€©æ§å ç«äžå šçå矀ïŒAIDSïŒã¯ãHIVãŠã€ã«ã¹ã ããåå ã§ãããšããã®ã¯ãããã誀解ã§ããããã¯åçŽã«çå®ã§ã¯ãããŸããã
åŸå€©æ§ïŒãŸãã¯äºæ¬¡æ§ïŒå ç«äžå šçã¯ãæäººã®ææçã®äž»ãªåå ã®äžã€ã§ãããããã®å ç«äžå šé害ã¯ãå ç«ç³»ã«éšåçãŸãã¯å šäœçã«åœ±é¿ãäžããããªãã®äœãããã€ãã®ç æ°ãææçã®ã¿ãŒã²ããã«ããããããŸãã(åºå ž)
å ç«äžå šé害ãå ç«ç³»ã«åœ±é¿ãäžãããšãããªãã®äœã¯ãã¯ã现èãç æ°ãšæŠãããšãã§ããªããªããŸãã(åºå ž)
ç°å¢äžã®ããã€ãã®èŠå ã¯ãäºæ¬¡çãªå ç«äžå šé害ãåŒãèµ·ããå¯èœæ§ããããŸãã(åºå ž)
äžè¬çãªãã®ãããã€ã玹ä»ããŸãã
æŸå°ç·çæ³ãååŠçæ³ã¯ã奜äžçæžå°çãšããŠç¥ãããäºæ¬¡çå ç«äžå šé害ãåŒãèµ·ããå¯èœæ§ããããŸãã
ããå ç«äžå šãŠã€ã«ã¹ïŒHIVïŒã«ããææçã¯ãåŸå€©æ§å ç«äžå šçå矀ïŒAIDSïŒãåŒãèµ·ããå¯èœæ§ããããŸãã
çœè¡ç ã¯ã骚é«ã®çްèããå§ãŸãçã§ãäºæ¬¡çãªå ç«äžå šã®äžçš®ã§ããäœã¬ã³ãã°ãããªã³è¡çãåŒãèµ·ããå¯èœæ§ããããŸãã
æ é€å€±èª¿ïŒäœéçºåœã®äººå£ã®50ïŒ ã眹æ£ããåŒåžåšææçãäžç¢ã«ãããããããªããŸãã
ããããããŸãäžè¬çã§ã¯ãªãåå ãšããŠã¯ãè¬ç©ãè¬å€ãæããããŸãã
ã€ãŸããè¬ãè¬å€ãåŸå€©æ§å ç«äžå šçå矀ãåŒãèµ·ããå¯èœæ§ã¯å®å šã«ãããã¹ã³ããã©ã³ãå ¬è¡è¡çå±ããã¥ãŒãžãŒã©ã³ãä¿å¥çãã«ããæ¿åºãè±åœå¥åº·å®å šå±ãè±åœåœå®¶çµ±èšå±ãç±³åœçŸç 察çã»ã³ã¿ãŒãçºè¡šããããŒã¿ã¯ãã³ããã19泚å°ããªã¹ãã«å ããã¹ãããšã匷ã瀺åããŠããã®ã§ãã
ç±³åœ
CDCã¯ãã¯ã¯ãã³ã®æå®³äºè±¡å ±åã·ã¹ãã ïŒVaccine Adverse Event Reporting SystemïŒãæ§ç¯ããã¯ã¯ãã³ã®æå®³äºè±¡ãå ±åããããšãã§ããŸããããŒã¿ããŒã¹ã®å šå®¹ã¯ãã¡ãã§ã芧ã«ãªããŸãã
ãã®ããŒã¿ããŒã¹ã«ã¯ã1950幎ãŸã§ããã®ãŒããç±³åœã§å©çšå¯èœãªãã¹ãŠã®ã¯ã¯ãã³ã«ã€ããŠå ±åãããå¯åå¿ãå«ãŸããŠããŸããããã§ãåŸå€©æ§å ç«äžå šçå矀ã«é¢é£ããäžè¬çãªç æ°ãææçã調ã¹ãããã«ããŒã¿ããŒã¹ãæ€çŽ¢ããŠã¿ããšããããã®ãããªçµæãåŸãããŸããã
以äžã®ã°ã©ãã¯ãVAERSã«å ±åãããå šã¯ã¯ãã³ã®ãã¡ããšã€ãºã«é¢é£ããå¯åå¿ã®å²åã幎å¥ã«ç€ºãããã®ã§ãã

2000幎以éã«å ±åããããšã€ãºã«é¢é£ããå¯åå¿ã®ãã¡51ïŒ ã2021幎ã«å ±åãããããã«2022幎ã«ã¯ãããŸã§ã®ãšãã16ïŒ ãå ±åãããŠãããšããããŒã¿ãåºãŠããŸãã
以äžã®ã°ã©ãã¯ããã¹ãŠã®ã¯ã¯ãã³ïŒã³ããã19ãžã£ããå«ãïŒã®å¯åå¿ãšããŠVAERSã«å ±åããããéåžžAIDSã«é¢é£ããäžè¬çãªããã®æ°ãå ±å幎å¥ã«ãã³ããã19ã¯ã¯ãã³ã®ã¿ãå ±å幎å¥ã«ç€ºãããã®ã§ã-ã

ã芧ã®ããã«2021幎ã2022幎ãšä»ã®ãšããå ±åãå€§å¹ ã«å¢ããŠããããã®å€§åã¯ã³ãã19ã®æ³šå°ã«èµ·å ãããã®ã§ãã
2000幎ãã2020幎ã®éã«ãããããã®ã¯ã¯ãã³ã®å¯åå¿ãšããŠå ±åããããšã€ãºã«é¢é£ããäžè¬çãªããã®å¹³åæ°ã¯21.3ã«çžåœããŸãã
2021幎ã«å¯åå¿ãšããŠå ±åãããAIDSã«é¢é£ããäžè¬çãªããã®ç·æ°ã¯430ã§ãã£ããããã¯1919ïŒ ã®å¢å ã§ããã
ãããããã¹ãŠã®å¯åå¿ãVAERSã«å ±åãããŠããããã§ã¯ãªãããšã«æ³šæããå¿ èŠããããŸããå®éãCDCã¯ãå®éã«ã·ã¹ãã ã«å ±åãããŠããå¯äœçšã¯ããã1ïœ10ïŒ ã§ããããšãèªããŠããŸããããããJessica Roseå士ã®èŠäºãªåæã«ããã°ãå ±åäžè¶³ã®å²åã¯å°ãªããšã41.3%ã§ãããšæ£ç¢ºã«æšå®ãããŠããŸãããã¡ããã芧ãã ããã
次ã®ã°ã©ãã¯ããã¹ãŠã®ã¯ã¯ãã³ïŒã³ããã-19ãžã£ããå«ãïŒã®å¯åå¿ãšããŠVAERSã«å ±åããããšã€ãºãå«ãåŸå€©æ§å ç«çŸæ£ã®æ°ãå ±å幎å¥ã«ããŸãã³ããã-19ã¯ã¯ãã³ã®ã¿ãå ±å幎å¥ã«ç€ºããŠããŸãã

ãããã2021幎ã2022幎ãšä»ã®ãšããåã³å ±åãå€§å¹ ã«å¢ããŠããããã®å€§åã¯ã³ãã19ã®æ³šå°ã«èµ·å ãããã®ã§ãã
2000幎ãã2020幎ã®éã«ãäœããã®ã¯ã¯ãã³ã®å¯åå¿ãšããŠå ±åãããåŸå€©æ§å ç«é害ã®å¹³åæ°ã¯31ã«çžåœããŸãã
2021幎ã«å¯åå¿ãšããŠå ±åãããåŸå€©æ§å ç«é害ã®ç·æ°ã¯ã386ä»¶ã§ãããããã¯1145ïŒ ã®å¢å ãæå³ããŸãã
以äžã®ã°ã©ãã¯ããã¹ãŠã®ã¯ã¯ãã³ïŒã³ããã-19ãžã£ããå«ãïŒã®å¯åå¿ãšããŠVAERSã«å ±åãããæè¡çã®ä»¶æ°ãå ±å幎å¥ã«ããŸãã³ããã-19ã¯ã¯ãã³ã®ã¿ãå ±å幎å¥ã«ç€ºããŠããŸã - ã

æè¡çã¯ãææçã«å¯Ÿããäœã®æ¥µç«¯ãªåå¿ã§ããçåœãè ããå»åŠçç·æ¥äºæ ã§ããæè¡çã¯ããã§ã«æã£ãŠããææçãå šèº«ã§é£éåå¿ãèµ·ããããšãã«èµ·ãããŸããæè¡çã®åå ãšãªãææçã¯ãèºãå°¿è·¯ãç®èãæ¶å管ã§çºçããããšãã»ãšãã©ã§ãã
2000幎ãã2020幎ã®éã«ãäœããã®ã¯ã¯ãã³ã®å¯åå¿ãšããŠå ±åãããæè¡çã®çäŸæ°ã¯ãå¹³åã§75äŸã§ãã
2021幎ã«å¯åå¿ãšããŠå ±åãããæè¡çã®ç·çäŸæ°ã¯1593äŸã§ãããããã¯2024ïŒ ã®å¢å ãæå³ããŸãã
ããã¯åãªãäžå¹žãªå¶ç¶ã ãšä¿¡ããŠããã®ã ãããïŒãããšããã¢ã¡ãªã«åœæ°ããã³ããã19泚å°ãåå ã§åŸå€©æ§å ç«äžå šçå矀ãçºçããŠãããšçŸç 管çã»ã³ã¿ãŒã«å ±åããŠããã®ãç®æããŠããã®ã§ããããïŒ
åœå®¶çµ±èšå±ïŒOffice for National StatiticsïŒãçºè¡šããæå®³ãªæ°å
åœå®¶çµ±èšå±ã¯ãè±åœæå€§ã®ç¬ç«ããå ¬ççµ±èšã®äœææ©é¢ã§ãããè±åœã®åœå®¶çµ±èšæ©é¢ãšããŠèªããããŠããŸããåœãå°åãå°æ¹ã¬ãã«ã§ãçµæžã人å£ã瀟äŒã«é¢ããçµ±èšã®åéãšå ¬è¡šãæ åœããŠããŸãã
ONSã¯ãã€ã³ã°ã©ã³ãã«ãããã¯ã¯ãã³æ¥çš®ç¶æ³å¥ã®æ»å ã«é¢ããææ°ã®ããŒã¿ã»ããã§ãå®å šæ¥çš®è ã®å šæ»å æ»äº¡çãéæ¥çš®è ã®å šæ»å æ»äº¡çããé«ãããšãæããã«ããŠããã
ã€ãŸããã¯ã¯ãã³æ¥çš®è ã¯Covid-19ã§æ»äº¡ãã確çãé«ãã ãã§ãªããããããåå ã§æ»äº¡ãã確çãé«ãã®ã§ããããã®ããšã¯ãã³ããã19ã®æ³šå°ãå ç«ç³»ã«èšãç¥ããªããã¡ãŒãžãäžããåŸå€©æ§å ç«äžå šçå矀ãçºçãããããšã瀺åããå ¥æå¯èœãªèšŒæ ãããã«è£ä»ãããã®ã§ããã
ONSããŒã¿ã»ããã®è¡š2ã«ã¯ãã€ã³ã°ã©ã³ãã§ã®å šæ»äº¡è ã«ã€ããŠã幎霢局å¥ã®ã¯ã¯ãã³æ¥çš®ç¶æ³ã«ããæéœ¢æšæºåæ»äº¡çã®ããŒã¿ãå«ãŸããŠããã
次ã®å³ã¯ãã€ã³ã°ã©ã³ãã®18æ³ãã39æ³ã®æäººã®10äžäººå¹Žåœããã®å šæ»å æ»äº¡ã«ã€ããŠãã¯ã¯ãã³æ¥çš®ç¶æ³å¥ã«å¹Žéœ¢æšæºåããæå¥æ»äº¡çã瀺ãããã®ã§ãããç·è²ã®ç·ã¯ã¯ã¯ãã³æªæ¥çš®è ã®æ»äº¡çã§ãå€åã¯ãããã®ã®ããã£ãšã»ãŒå®å®ããŠããã

ããããä»ã®ç·ã¯ãç°ãªãã¯ã¯ãã³æ¥çš®ã®ç¶æ³ã衚ããŠãããéåžžã«æ°ã«ãªããšããã§ããããªã¬ã³ãžãé»è²ããã³ã¯ã®ç·ã¯ã1åç®ã2åç®ã3åç®ã®æ¥çš®ãã21æ¥ä»¥å ã®æ»äº¡çã衚ããŠããããããŠãã¯ã¯ãã³æ¥çš®çŽåŸããæ»äº¡ãªã¹ã¯ãå€§å¹ ã«äžæããããšãæããã«ãªã£ãã
ããããæãæžå¿µãããã®ã¯ãå°ãªããšã21æ¥åã«ã¯ã¯ãã³æ¥çš®ãåããäººã®æ»äº¡çã§ãããæ¬¡ã®ã°ã©ãã§ããæç¢ºã«èŠãããšãã§ããã

2021幎1æãã¯ã¯ãã³æªæ¥çš®è ã®10äžäººå¹Žåœããã®æ»äº¡çã¯67.7ã«çžåœããããã®åŸã5æã«ã¯33.1ãŸã§åææ¯ã§äœäžãã6æã«ã¯44.8ãšåã³äžæãããããããæ»äº¡ãã21æ¥åãŸã§ã«1åã§ãæ¥çš®ããŠãã人ã¯ããã®éãã§ã¯ãããŸããã
2021幎1æã®äžéšæ¥çš®è ã®10äžäººå¹Žåœããã®æ»äº¡çã¯119.9ã«çžåœãããã€ãŸããæ»äº¡çã¯ã¯ã¯ãã³æªæ¥çš®è ã®æ»äº¡çãã77%ãé«ãã£ãã®ã§ãããã®åŸã2æã«ã¯10äžäººåœããã®æ»äº¡çã68.3ãŸã§äžããã3æã«ã¯90.1ãŸã§äžæãã4æã«ã¯108.8ãšãªã£ãã
ã€ãŸãããã®æç¹ã§äžéšæ¥çš®è ã®æ»äº¡çã¯ãéæ¥çš®è ã®æ»äº¡çãã193.3ïŒ é«ãã£ãã®ã§ããããããã2åç®ãæ¥çš®ããŠéããªããäºæ ã¯ããã«æªåããã
äºåæ¥çš®è ïŒå°ãªããšã21æ¥åïŒã®æ»äº¡çãæãé«ãã£ãã®ã¯2021幎9æã§ã10äžäººå¹Žããã125.9äººãæ»äº¡ããŠãããåãæãã¯ã¯ãã³æªæ¥çš®è ã®æ»äº¡çã¯46.8ã«çãããããã«ã¯ã¯ãã³æ¥çš®è ã®æ»äº¡çã¯ãã¯ã¯ãã³æªæ¥çš®è ã®æ»äº¡çãã169ïŒ é«ãã£ããšããããšã§ãã
ããããçµ±èšçã«æã倧ããªå·®ãçããã®ã¯2021幎11æã§ãããã¯ã¯ãã³æªæ¥çš®è ã®æ»äº¡çã¯10äžäººå¹Žããã33.4人ã«çããã£ãã®ã«å¯Ÿããããã«ã¯ã¯ãã³æ¥çš®è ã®æ»äº¡çã¯107人ã«çããã£ãããã®å·®ã¯220.4ïŒ ã
次ã®å³ã¯ãã€ã³ã°ã©ã³ãã®18æ³ãã39æ³ã®æäººã«ããã10äžäººå¹Žåœããã®å šæ»å æ»äº¡ã«ã€ããŠãã¯ã¯ãã³æ¥çš®ç¶æ³å¥ã«21幎1æ1æ¥ãã22幎1æ31æ¥ã®éã«çºçããå¹³åå¹Žéœ¢æšæºåæ»äº¡çã瀺ããŠããã

ã¯ã¯ãã³æªæ¥çš®è ã®ãã®13ã¶æéã®å¹³åæ»äº¡çã¯ã10äžäººå¹Žåœãã43.9人ã«çžåœãããããããã¯ã¯ãã³æ¥çš®åŸ21æ¥ä»¥å ã®æ»äº¡çãç¡èŠãããšãå®ã¯ãã¹ãŠã®æ¥çš®ç¶æ³ã®äžã§æãäœãæ»äº¡çã§ãããããã«ã¯Covid-19ã®æ»äº¡çãå«ãŸããŠããããšããããã
éšåæ¥çš®ïŒå°ãªããšã21æ¥åïŒã®å¹³åæ»äº¡çã¯10äžäººããã66.3人ã«çžåœãããäžæ¹ã2åæ¥çš®ïŒå°ãªããšã21æ¥åïŒã®å¹³åæ»äº¡çã¯ã21幎1æ1æ¥ãã22幎1æ31æ¥ã®éã«10äžäººå¹Žåœãã84.02äººã®æ»äº¡ã«çžåœããã
21幎1æ1æ¥ãã22幎1æ31æ¥ãŸã§ã®å¹³åã§ã1åæ¥çš®è ã¯æªæ¥çš®è ãã51ïŒ ã2åæ¥çš®è ã¯æªæ¥çš®è ãã91.4ïŒ æ»äº¡ããããããšã瀺ãããã
äœãã倧ããééã£ãŠãããããã¯ã³ãã19泚å°ã®ããã
çŸå®ã®ããŒã¿ã¯åãã€ããªãã
ã³ãã19泚å°ãåãããšãã³ãã19ã«ææãã確çãé«ããªããã³ãã19ã§å ¥é¢ãã確çãé«ããªããã³ãã19ã§æ»äº¡ãã確çãé«ããªãã®ã§ãããããããæ³šå°ãåãã人ãäœããã®åå ã§æ»äº¡ããå¯èœæ§ãé«ããªãããšã倿ããã
ãã®äºå®ãšããšã€ãºã«é¢é£ããç æ°ãçãææçã®VAERSã¬ããŒãããã³ããã19泚å°ã®å°å ¥åŸã®2021幎ã«1145ïŒ ãã33,715ïŒ å¢å ãããšããäºå®ãåããããšãã¹ã³ããã©ã³ãããã¥ãŒãžãŒã©ã³ããã«ãããè±åœãç±³åœããããŠãã®ä»ã®åœã ã®æ¿åºã¯ãã³ããã19泚å°ãæ£è ã«æ°ãã圢ã®åŸå€©å ç«äžå šçå矀ãçºçãããŠãããšèªããæãæ¥ãã®ã§ã¯ãªãã ãããã